CTH522-elicited antibodies have functionality in in vitro neutralization assays and in vivo challenge with C. trachomatis intravaginally at 6 weeks and 1 year postvaccination and also through passive transfer of antibodies to Rag1 knockout mice, which prevented the establishment of an infection in approximately half of mice (28). The gene discussed is RAG1; the disease is infection.